Parkside Medical Anesthesia is categorized under Anesthesiologists in Buffalo, NY and active since 1991.
Parkside Medical Anesthesia was established in 1991, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Anesthesiologists business, which does work in the B2C market, and is classified as a Anesthesiologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jason Conant, Administrator at the company’s single location by writing to 2121 Main St # 209, Buffalo, New York NY 14214 or by phoning (716) 836-7510. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Parkside Medical Anesthesia |
| Contact Person: | Jason Conant, Administrator |
| Address: | 2121 Main St # 209, Buffalo, New York 14214 |
| Phone Number: | (716) 836-7510 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1991 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Anesthesiologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Parkside Medical Anesthesia was started in 1991 to provide professional Anesthesiologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Jason Conant, Administrator for inquiries that concern Parkside Medical Anesthesia by calling the company number (716) 836-7510, as your correspondence is most welcome. Additionally, the physical location of the single location of Parkside Medical Anesthesia can be found at the coordinates 42.92821,-78.85084 as well as the street address 2121 Main St # 209 in Buffalo, New York 14214.
For its online presence, you may visit Parkside Medical Anesthesia’s website at and engage with its social media outlets through on Twitter and on Facebook.